Diagnostics are the most important tools that empower the health workforce in the identification of diseases or health conditions. They allow the initiation of treatments in order to avoid further complications and costly treatments for patients.
To boost supply chain resilience and regional self-reliance, WHO has been actively advocating for locally manufactured quality-assured medicines and diagnostics. In 2023, a Kenya-based pharmaceutical company became the first African manufacturer to receive WHO prequalification to produce tenofovir disoproxil fumarate, lamivudine and dolutegravir (TLD), a WHO-recommended first-line ...
To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses. The latest edition, published today, includes WHO-recommended COVID-19 ...
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself.
The World Health Organization (WHO) has released its 2023 Essential Diagnostics List (EDL), which is an evidence-based register of in vitro diagnostics (IVD) that supports countries to make national diagnostic choices.
The Landscape analysis of commercially available and pipeline in vitro diagnostics for fungal priority pathogens focuses on commercially available diagnostic products and pipeline diagnostic products for invasive fungal diseases (IFDs) and on the identifiable gaps.
The technology transfer support made possible through this agreement aligns well with the objectives of WHA Resolution 76.5 on strengthening diagnostics capacity which urges countries to commit resources to invest in research and product development and to promote local production capacity for diagnostics, particularly in developing countries. Access to diagnostics that facilitate test and ...